Tarek Suhayl Mansour

USPTO Granted Patents = 28 (Patent Applications = 7)

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 66(Granted Patents)

Company Filing History:

Sabila Biosciences LLC

patents

2 out of 3

Pramana Pharmaceuticals Inc.

Wyeth Holdings Corporation

patents

6. 1 out of 109

Xenon Pharmaceuticals Inc.

patents

7. 1 out of 23

Viropharma Incorporated

patents

8. 1 out of 2

Wyeth, Five Giralda Farms

patents

where one patent can have more than one assignee

Years Active: 2003-2024

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12037328 - Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 (2024-07-16),

2. 10906894 - Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of g protein-coupled receptor 119 (2021-02-02),

3. 10844038 - 1,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions (2020-11-24),

4. 10351540 - 1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions (2019-07-16),

5. 10246444 - 1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions (2019-04-02),

6. 10022381 - Triazine compounds as PI3 kinase and mTOR inhibitors (2018-07-17),

7. 9487535 - Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents (2016-11-08),

8. 9174963 - Triazine compounds as PI3 kinase and MTOR inhibitors (2015-11-03),

9. 8859542 - Triazine compounds as PI3 kinase and mTOR inhibitors (2014-10-14),

10. 8748421 - Triazine compounds as P13 kinase and MTOR inhibitors (2014-06-10),

11. 8575159 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-11-05),

12. 8445486 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-05-21),

13. 8217036 - Triazine compounds as PI3 kinase and mTOR inhibitors (2012-07-10),

14. 8101590 - 9-aminocarbonylsubstituted derivatives of glycylcyclines (2012-01-24),

15. 8039469 - Triazine compounds as PI3 kinase and mTOR inhibitors (2011-10-18),

Sure, I can help you with that. Here is the article about inventor Tarek Suhayl Mansour:

Title: Unveiling the Genius of Tarek Suhayl Mansour: A Maestro of Innovation in New City, NY

Introduction:

Tarek Suhayl Mansour, a prominent inventor based in New City, NY, is a visionary mind with a knack for groundbreaking inventions. With an impressive portfolio of 27 patents, Mansour has left an indelible mark on the realm of scientific innovation.

Latest Patents:

Mansour's latest patents showcase his expertise in cutting-edge pharmaceutical compounds and their diverse applications. His inventions include compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, which act as agonists of G protein-coupled receptor 119, offering potential treatments for Type 2 diabetes mellitus and related metabolic disorders. Additionally, his 1,2-dithiolane compounds show promise in neuroprotection, autoimmune, and cancer treatments.

Career Highlights:

Mansour has made significant contributions during his tenure at renowned companies such as Wyeth and Sabila Biosciences LLC. His groundbreaking research and innovative solutions have significantly advanced the fields of pharmaceuticals and biotechnology.

Collaborations:

Throughout his career, Mansour has collaborated with esteemed professionals in the industry, including Aranapakam Mudumbai Venkatesan and Ariamala Gopalsamy. Together, they have collectively worked towards pushing the boundaries of scientific exploration and creating impactful solutions for complex medical challenges.

Conclusion:

In conclusion, Tarek Suhayl Mansour's exceptional talent and dedication to innovation have cemented his legacy as a pioneering inventor in the realm of pharmaceuticals and biotechnology. His relentless pursuit of scientific excellence continues to inspire and shape the future of medical advancements.

This text is generated by artificial intelligence and may not be accurate.